Literature DB >> 11149946

Regulating ankyrin dynamics: Roles of sigma-1 receptors.

T Hayashi1, T P Su.   

Abstract

Ankyrin is a cytoskeletal adaptor protein that controls important cellular functions, including Ca(2+) efflux at inositol 1,4,5-trisphosphate receptors (IP(3)R) on the endoplasmic reticulum. The present study found that sigma-1 receptors (Sig-1R), unique endoplasmic reticulum proteins that bind certain steroids, neuroleptics, and psychotropic drugs, form a trimeric complex with ankyrin B and IP(3)R type 3 (IP(3)R-3) in NG-108 cells. The trimeric complex could be coimmunoprecipitated by antibodies against any of the three proteins. Sig-1R agonists such as pregnenolone sulfate and cocaine caused the dissociation of an ankyrin B isoform (ANK 220) from IP(3)R-3. This effect caused by Sig-1R agonists was blocked by a Sig-1R antagonist. The degree of dissociation of ANK 220 from IP(3)R-3 caused by Sig-1R ligands correlates excellently with the ligands' efficacies in potentiating the bradykinin-induced increase in cytosolic free Ca(2+) concentration. Immunocytohistochemistry showed that Sig-1R, ankyrin B, and IP(3)R-3 are colocalized in NG-108 cells in perinuclear areas and in regions of cell-to-cell communication. These results suggest that Sig-1R and associated ligands may play important roles in cells by controlling the function of cytoskeletal proteins and that the Sig-1R/ANK220/IP(3)R-3 complex regulating Ca(2+) signaling may represent a site of action for neurosteroids and cocaine.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11149946      PMCID: PMC14614          DOI: 10.1073/pnas.98.2.491

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

Review 1.  The role of ankyrin and spectrin in membrane transport and domain formation.

Authors:  M A De Matteis; J S Morrow
Journal:  Curr Opin Cell Biol       Date:  1998-08       Impact factor: 8.382

2.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.

Authors:  W R Martin; C G Eades; J A Thompson; R E Huppler; P E Gilbert
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

3.  Cloning and functional characterization of a sigma receptor from rat brain.

Authors:  P Seth; Y J Fei; H W Li; W Huang; F H Leibach; V Ganapathy
Journal:  J Neurochem       Date:  1998-03       Impact factor: 5.372

4.  The membrane attachment protein for spectrin is associated with band 3 in human erythrocyte membranes.

Authors:  V Bennett; P J Stenbuck
Journal:  Nature       Date:  1979-08-09       Impact factor: 49.962

5.  Immunoreactive forms of human erythrocyte ankyrin are present in diverse cells and tissues.

Authors:  V Bennett
Journal:  Nature       Date:  1979-10-18       Impact factor: 49.962

6.  Two novel sigma receptor ligands, BD1047 and LR172, attenuate cocaine-induced toxicity and locomotor activity.

Authors:  K A McCracken; W D Bowen; B R de Costa; R R Matsumoto
Journal:  Eur J Pharmacol       Date:  1999-04-16       Impact factor: 4.432

7.  Ca(2+) signaling via sigma(1)-receptors: novel regulatory mechanism affecting intracellular Ca(2+) concentration.

Authors:  T Hayashi; T Maurice; T P Su
Journal:  J Pharmacol Exp Ther       Date:  2000-06       Impact factor: 4.030

Review 8.  Neurosteroids: a novel function of the brain.

Authors:  E E Baulieu
Journal:  Psychoneuroendocrinology       Date:  1998-11       Impact factor: 4.905

9.  Antiproliferative effects of SR31747A in animal cell lines are mediated by inhibition of cholesterol biosynthesis at the sterol isomerase step.

Authors:  C Labit-Le Bouteiller; M F Jamme; M David; S Silve; C Lanau; C Dhers; C Picard; A Rahier; M Taton; G Loison; D Caput; P Ferrara; J Lupker
Journal:  Eur J Biochem       Date:  1998-09-01

10.  Ankyrin-B is required for intracellular sorting of structurally diverse Ca2+ homeostasis proteins.

Authors:  S Tuvia; M Buhusi; L Davis; M Reedy; V Bennett
Journal:  J Cell Biol       Date:  1999-11-29       Impact factor: 10.539

View more
  109 in total

1.  The sigma receptor agonist SA4503 both attenuates and enhances the effects of methamphetamine.

Authors:  Kelli R Rodvelt; Clark E Oelrichs; Lucas R Blount; Kuo-Hsien Fan; Susan Z Lever; John R Lever; Dennis K Miller
Journal:  Drug Alcohol Depend       Date:  2011-02-01       Impact factor: 4.492

Review 2.  Sigma receptors: biology and therapeutic potential.

Authors:  Xavier Guitart; Xavier Codony; Xavier Monroy
Journal:  Psychopharmacology (Berl)       Date:  2004-06-10       Impact factor: 4.530

3.  Sigma1 receptor upregulation after chronic methamphetamine self-administration in rats: a study with yoked controls.

Authors:  Roman Stefanski; Zuzana Justinova; Teruo Hayashi; Minoru Takebayashi; Steven R Goldberg; Tsung-Ping Su
Journal:  Psychopharmacology (Berl)       Date:  2004-03-17       Impact factor: 4.530

Review 4.  Sigma receptors: potential targets for a new class of antidepressant drug.

Authors:  James A Fishback; Matthew J Robson; Yan-Tong Xu; Rae R Matsumoto
Journal:  Pharmacol Ther       Date:  2010-05-11       Impact factor: 12.310

5.  The sigma-1 receptor chaperone as an inter-organelle signaling modulator.

Authors:  Tsung-Ping Su; Teruo Hayashi; Tangui Maurice; Shilpa Buch; Arnold E Ruoho
Journal:  Trends Pharmacol Sci       Date:  2010-10-01       Impact factor: 14.819

6.  Implications of immune system in stroke for novel therapeutic approaches.

Authors:  Aaron A Hall; Keith R Pennypacker
Journal:  Transl Stroke Res       Date:  2010-01-13       Impact factor: 6.829

7.  Anti-amnesic effect of dimemorfan in mice.

Authors:  Hui-Hung Wang; Jyh-Wei Chien; Yueh-Ching Chou; Jyh-Fei Liao; Chieh-Fu Chen
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

8.  Photoaffinity labeling of the sigma-1 receptor with N-[3-(4-nitrophenyl)propyl]-N-dodecylamine: evidence of receptor dimers.

Authors:  Uyen B Chu; Subramaniam Ramachandran; Abdol R Hajipour; Arnold E Ruoho
Journal:  Biochemistry       Date:  2013-01-28       Impact factor: 3.162

Review 9.  Sigma-1 receptor ligands: potential in the treatment of neuropsychiatric disorders.

Authors:  Teruo Hayashi; Tsung-Ping Su
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

10.  Blockade of Tau hyperphosphorylation and Aβ₁₋₄₂ generation by the aminotetrahydrofuran derivative ANAVEX2-73, a mixed muscarinic and σ₁ receptor agonist, in a nontransgenic mouse model of Alzheimer's disease.

Authors:  Valentine Lahmy; Johann Meunier; Susanna Malmström; Gaelle Naert; Laurent Givalois; Seung Hyun Kim; Vanessa Villard; Alexandre Vamvakides; Tangui Maurice
Journal:  Neuropsychopharmacology       Date:  2013-03-14       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.